← Eichor
Study identifier: NCT06037967 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders

Condition: Allergic Diseases · Asthma · Mast Cell Disorders  ·  Sponsor: University Hospital, Toulouse

PhaseN/A
Planned participants3200
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

This study aims to build up a clinico-biological bank of samples from patients suspected of or suffering from allergic diseases (including asthma) or mast cell diseases in order to support future research in the field of allergic diseases. The biobank will help to identify new prognostic, diagnostic and/or predictive biomarkers.

This description comes directly from the study's public registry record.

Talk to the study team

Laurent GUILLEMINAULT, MD  ·  05 67 77 17 51  ·  guilleminault.l@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Laurent GUILLEMINAULTToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06037967